Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactobacillus delbrueckii spp. bulgaricus LB-14 is a specific strain of Lactobacillus delbrueckii subspecies bulgaricus, a type of lactic acid bacteria commonly utilized as a probiotic. Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host, typically by improving or restoring the gut flora. This strain is generally recognized for its role in fermentation processes and its potential contributions to maintaining a healthy gut environment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lactobacillus delbrueckii spp. bulgaricus LB-14.